Neurotransmitter Pro Liquid
NDC Package 44911-0710-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Neurotransmitter Pro (aethusa cynapium, ginkgo biloba, kali phosphoricum, cerebrum suis, hypothalamus suis, adenosinum triphosphoricum dinatrum, alumina, anacardium orientale, arsenicum album, cortisone aceticum, levothyroxinum, lycopodium clavatum, nadidum, phosphorus, ubidecarenonum, zincum metallicum, acetylcholine chloride, dopamine hydrochloride, gaba (gamma-aminobutyric acid), histaminum hydrochloricum, melatonin, norepinephrine (bitartrate), serotonin (hydrochloride), oxytocin) liquids is adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0710.

Identification & Billing

NDC Package Code
44911-0710-1
Package Description
30 mL in 1 BOTTLE, DROPPER
Product Code
44911-0710
11-Digit Billing Format
44911071001

Clinical Specifications

Proprietary Name
Neurotransmitter Pro
Non-Proprietary Name
Aethusa Cynapium, Ginkgo Biloba, Kali Phosphoricum, Cerebrum Suis, Hypothalamus Suis, Adenosinum Triphosphoricum Dinatrum, Alumina, Anacardium Orientale, Arsenicum Album, Cortisone Aceticum, Levothyroxinum, Lycopodium Clavatum, Nadidum, Phosphorus, Ubidecarenonum, Zincum Metallicum, Acetylcholine Chloride, Dopamine Hydrochloride, Gaba (gamma-aminobutyric Acid), Histaminum Hydrochloricum, Melatonin, Norepinephrine (bitartrate), Serotonin (hydrochloride), Oxytocin
Substance Name
Aethusa Cynapium Whole; Ginkgo; Dibasic Potassium Phosphate; Sus Scrofa Cerebrum; Sus Scrofa Hypothalamus; Adenosine Triphosphate Disodium; Aluminum Oxide; Semecarpus Anacardium Juice; Arsenic Trioxide; Cortisone Acetate; Levothyroxine; Lycopodium Clavatum Spore; Nadide; Phosphorus; Ubidecarenone; Zinc; Acetylcholine Chloride; Dopamine Hydrochloride; .gamma.-aminobutyric Acid; Histamine Dihydrochloride; Melatonin; Norepinephrine Bitartrate; Serotonin Hydrochloride; Oxytocin
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional.Consult a physician for use in children under 12 years of age.

Regulatory & Marketing

Labeler Name
Energique, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
05-06-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 44911-0710-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Neurotransmitter Pro, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains aethusa cynapium whole; ginkgo; dibasic potassium phosphate; sus scrofa cerebrum; sus scrofa hypothalamus; adenosine triphosphate disodium; aluminum oxide; semecarpus anacardium juice; arsenic trioxide; cortisone acetate; levothyroxine; lycopodium clavatum spore; nadide; phosphorus; ubidecarenone; zinc; acetylcholine chloride; dopamine hydrochloride; .gamma.-aminobutyric acid; histamine dihydrochloride; melatonin; norepinephrine bitartrate; serotonin hydrochloride; oxytocin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on May 06, 2024. The current certification is valid through December 31, 2026.

How is this Energique, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911071001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
44911-0710-1
11-Digit CMS (5-4-2)
44911-0710-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.